Arnold M. Baskies, Anixa Biosciences option exercise and tax withholding

Director, SEC Form 4, filed on July 29, 2026
+572 sharesnet change in holding. Not an open-market purchase or sale
Transaction date
July 27, 2026
Shares held after
135,572Direct ownership
Change in holding
+0.42%From the transactions in the filing
Filing rows
2None is a purchase or sale

Price context

ANIX daily close, Apr 20 to October 26, 2026
$3.75$2.35
Daily close
Grants, options, tax
Transaction price
Not reportedNot an open-market trade
Close on trade date
$3.46July 27, 2026
Latest close
$2.93October 26, 2026
Since the trade
−15.32%vs the close on trade date

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
6,000
$3.13
$18,780
141,000
Tax withholding
Common stockDirect
5,428
$3.46
$18,781
135,572

Recent filings at Anixa Biosciences

Full history
PersonTransactionAmount or sharesDate
Lewis H. Titterton Jr.Director
Purchase
$23,840
Amit KumarCEO
Purchase
$21,760
Michael CatelaniCFO
Purchase
$15,620
Amit KumarCEO
Purchase
$19,460
Arnold M. BaskiesDirector
Purchase
$13,800
Lewis H. Titterton Jr.Director
Purchase
$27,300
Amit KumarCEO
Purchase
$13,800
Amit KumarCEO
Purchase
$8,250